Amersham logoAnswering life's questions - Annual Report & Accounts 2001
Points of viewThe ReportMarket reports
DownloadsHome
Remuneration report
Print this page Next page
  Previous page  
 

This report sets out the policy and disclosures in relation to Directors’ remuneration.

The Remuneration Committee (the Committee) is responsible for determining the remuneration and the terms and conditions of service of the Executive Directors. During the year, the Committee was made up of six independent Non-Executive Directors. The membership of the Committee comprised Mr R D Lapthorne (the Chairman of the Board) as Chairman, Mr J Fr Odfjell (the Deputy Chairman of the Board), Mr D H Brydon, Professor E Thorsby, Dr J S Patterson and Mr J F Rejeange. The Chief Executive attends the meetings of the Committee, except when his own remuneration is being considered.

In 2001, the Board accepted all the recommendations of the Remuneration Committee without amendment.

The remuneration of the Non-Executive Directors is reviewed by the Chief Executive who makes recommendations to the Board. The Board determines the remuneration of the Non-Executive Directors within the limits set out in the Articles of Association. The responsibilities of the role and the level of fees paid in UK organisations of a similar size and complexity to Amersham are considered in setting remuneration policy for Non-Executive Directors.

The Report of the auditors on the financial statements covers the disclosures contained in this report that are specified for audit by the Financial Services Authority.

Remuneration policy for Executive Directors
In determining the remuneration policy for Executive Directors, the Committee has considered a number of factors including:

  • the importance of attracting, retaining and motivating management of the appropriate calibre to further the success of the business;
  • the linking of reward to both individual and business performance; and
  • ensuring that the interests of the Directors are aligned with those of the shareholders.

To this end, the Remuneration Committee seeks to pay Executive Directors base salaries at a median level and incentives (in the form of bonuses and long term option arrangements) at an upper quartile level when compared to compensation levels and packages in other companies of comparable size and complexity, and also in companies in the same business sector. The total package is aimed to lie between the median and upper quartile.

In establishing this policy, the Committee obtains advice from independent consultants, New Bridge Street Consultants.

In 2001, the Remuneration Committee considered a valuation of all elements of Executive Directors’ remuneration to ensure that it was aware of the total remuneration within the company and its selected comparators. This valuation approach included the use of the Black-Scholes option valuation technique for assessing the value of long term incentives. The same approach will be used in 2002.

The Remuneration Committee believes that the policy adopted in its remuneration of Executive Directors and senior managers has contributed to the sustained financial success and long termgrowth of the company. This policy has enabled the company to both attract and keep a high calibre management team – essential for a well run and growing business. The strong shareholder returns achieved by the company are a testament to this policy, which reflects best market practice.

The current elements of the remuneration packages can be summarised as follows:

Service contracts
In the year under review, Executive Directors were employed on rolling contracts subject to two years’ notice when given by the company or one year’s notice if given by the Director. The Committee has given careful consideration to the case for reducing this two-year notice period and it has been agreed to reduce the two-year rolling period to one year. With effect from 1 March 2002 all Executive Directors will be employed on rolling contracts subject to one year’s notice if given by the company and six months notice if given by the Executive Director. Non-Executive Directors do not have service contracts.

Details of the Directors retiring by rotation at the Annual General Meeting to be held on 8 May 2002 are given in the Report of the Directors. Of the Directors retiring, Mr R D Lapthorne and Mr J Fr Odfjell are members of the Remuneration Committee.

Compensation
No compensation payments were paid to Mr R E Long when he resigned from the Board on 23 March 2001. He remained an employee of the company up to 30 June 2001, when he retired. On 1 July 2001, he entered into a consultancy agreement with the company to provide consultancy services for an initial period of one year. Details of payments made under this consultancy agreement are disclosed in the notes to the Remuneration table in the Remuneration report.

Base salary and benefits
Base salaries for Executive Directors are reviewed by the Committee, normally annually, having regard to competitive market practice and individual performance for the financial year. The Committee aims to pay Executive Directors median level base salaries.

The principal benefits provided to the Executive Directors are a fully-expensed car, pension, and life, disability and health insurance and, where appropriate, relocation expenses.

Annual performance-related bonus
The annual performance-related bonus is dependent upon a number of factors. The level of bonus is payable on a sliding scale between 0% and 100% of the base salary. Bonus payments totalling £1,125,420 (2000 – £871,906) have been approved, based on the financial performance measures achieved for 2001 including growth in earnings per share, cash flow, sales and operating profit, and performance against a number of personal objectives for each Executive Director.

Share option schemes
The company operates a UK Inland Revenue approved Sharesave (SAYE) share option scheme which is available to all UK employees, including Executive Directors. The scheme is subject to a cumulative maximum investment of £250 per month for each individual. The share option runs for three, five or seven years. At the end of the chosen option period the shares may be purchased by the employee at a 20% discount to the share price at the start of the period. The Plan is due to be renewed in 2002 and a resolution to this effect shall be put to the Annual General Meeting together with a resolution seeking approval for the introduction of an all-employee Inland Revenue approved Share Incentive Plan. Further details are contained in the Chairman’s Letter to shareholders to be dated 28 March 2002.

In the US, the company operates a US tax qualified Stock Purchase Plan which was approved by shareholders at the Annual General Meeting held in May 2000. The plan is subject to a maximum annual investment of $25,000 or 10% of pay for each individual. Employees save for a six month period, at the end of which shares are purchased at a 15% discount to the share price either at the beginning or the end of the savings period. This Plan is not available to Executive Directors.

During the year, options over 1,000 shares each were granted to all employees in the group, except for the four Executive Directors, under the company’s ‘Options for All’ programme, to mark the new corporate identity of the group and to reinforce the ‘one company’ strategy. These options were granted under the rules of the Executive Share Option Scheme approved by shareholders at the Annual General Meeting in 2001. The options are not subject to performance conditions and are normally exercisable after three but not more than six years from the date of grant. Options were granted on a tax approved basis as far as possible in those countries where local legislation permitted – UK, US, Ireland, France and Italy. In addition, in those countries where it was not tax efficient to grant options over shares or there were legal constraints, equivalent cash options were granted instead of conventional share options.

Additionally, tax approved and unapproved Executive Share Option Schemes are available to Executive Directors and senior managers. The unapproved schemes permit the grant of equivalent cash options in respect of participants in those countries where it is not tax efficient to grant options over shares or there are legal constraints. For the purpose of hedging a cash option, a corresponding trust option over new issue shares is granted to the Amersham plc ESOP Trust. Options to acquire shares in the company are awarded on a discretionary basis by the Remuneration Committee. Options granted prior to 2001 are normally exercisable after three but not more than ten years from the date of grant. Options granted in the US in 2000 and to senior managers worldwide from 2001 onwards become exercisable in four equal tranches on the first, second, third and fourth anniversaries of the date of grant.

Options granted to Executive Directors prior to 2001 under the terms of the 1993 Executive Share Option Scheme are subject to the attainment of growth in the company’s earnings per share of at least 6% more than the increase in the Retail Prices Index over any three consecutive financial years prior to the exercise of the option.

Options granted to Executive Directors from 2001 under the terms of the 2001 Executive Share Option Scheme are not normally exercisable until the third anniversary of the date of grant and to the extent that the performance conditions specified prior to the grant of the option have been satisfied. For options granted to Executive Directors in 2001, 50% of each option grant will vest if the company’s normalised earnings per share growth (as determined by the Remuneration Committee) matches or exceeds the growth in the Retail Prices Index plus 3% per annum. The entire option grant will vest if the company’s normalised earnings per share growth matches or exceeds the growth in the Retail Prices Index plus 5% per annum. There is proportionate vesting between 3% and 5%. Performance is always measured from the end of the financial year prior to the grant of the option. 25% of the options may vest after one year with a further 25% after two years and a further 50% after three years. To the extent that these targets are not achieved by those times, the performance period will be extended, one financial year at a time. To the extent that the performance conditions have not been met by the fifth anniversary of the grant, the option lapses.

Options granted to senior managers worldwide from 2001 are not subject to performance conditions.

Under the rules of this scheme, the maximum annual grant of options available to Executive Directors is two times their annual base salary. In 2001, option grants were made to Executive Directors at this level. In 2002, it is also proposed to grant Executive Directors options over shares valued at two times their annual base salary.

The beneficial interests of the Executive Directors in share options are shown at the end of this report.

The Remuneration report continues on the next page »
[Page 1 of 3]


   
Previous pageNext page

© Amersham plc - All rights reserved  Privacy policy - Terms & conditions - GE Healthcare